Updates on job opportunities, publishing, events and more for our treatment community, addiction research
By Angela Zhou
New & Next: Treatment Centers
Next CEO of Caron Treatment Centers: Bradley Sorte
Caron Treatment Centers announced Bradley F. Sorte will be their new CEO, effective July 1, 2021, after current CEO Doug Tieman’s retirement. The current chief strategy and growth officer for Caron, Sorte was unanimously selected by its board of trustees.
New & Next: Conferences & Webinars
2020 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention
The annual NIDA–NIAAA Frontiers in Addiction Research Mini-Convention for 2020 will be held as a virtual meeting on Jan. 7-8, 2021, after having been rescheduled from October 2020 due to the pandemic. The mini-convention provides a forum for presentations and discussions of neuroscience and addiction research. The two mini-symposia that will be presented are “Mapping the Addiction Neurocircuitry” and “AI-based Approaches to Addiction Pathophysiology and Novel Therapeutics.” The event is free and open to the public with registration.
NAADAC Free Webinar Series
NAADAC is offering addiction-specific education in its 2021 Free Webinar Series. NAADAC members can earn, at no cost, continuing education hours (CEs) for any webinar of the series, while non-members can pay to receive the CEs. The webinar “Collision of SUD and COVID-19: A NIDA Update” is scheduled Friday, Dec. 18, 2020, from 12:00-2:00 p.m. ET and offers two CEs. Registration is free and open.
NIDA-funded Seminar Discussion Series on Recovery Community Centers
For the NIDA-funded Seminar Discussion Series on Recovery Community Centers (RCCs), presenter Tom Hill of the National Council for Behavioral Health will present “The Origins of Recovery Community Centers: Context and History.” The seminar is scheduled for Friday, Dec. 18, at 12:00 p.m. ET, and registration is free and open.
New & Next: Research
University of Cincinnati Clinical Trial
A study funded by the National Institutes of Health and led by University of Cincinnati researchers is investigating whether a medication currently used to treat pregnant women who suddenly stop using drugs and alcohol may be more beneficial as an extended-release medication. To participate in the study, you need to be an expectant mother between the ages of 18 and 41 who struggles with opioid use. Learn more about the study or how to join as a participant.
